StockData
Zimmer Biomet Holdings, Inc. logo

Zimmer Biomet Holdings, Inc. (ZBH) stock

ZBHNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3018% below fair value
$102.09+0.68 (+0.67%)

Close on Nov 17, 2026Market cap $19.47BP/E 24.8Yield 0.94%

Zimmer Biomet r&d expenses

Research and development expenses are spending on new products and technology.

Zimmer Biomet's R&D Expenses for the twelve months ending Jun 30, 2026 was $442.80M, down 0.3% year over year. For fiscal 2025 it was $458.50M, up 4.8% from the year before. Over ten years it grew 5.5% a year on average. The highest annual figure on record is $458.70M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$458.50M+4.8%
FY2024Dec 31, 2024$437.40M-4.6%
FY2023Dec 31, 2023$458.70M+13.0%
FY2022Dec 31, 2022$406.00M-6.8%
FY2021Dec 31, 2021$435.80M+35.0%
FY2020Dec 31, 2020$322.80M-28.2%
FY2019Dec 31, 2019$449.30M+14.7%
FY2018Dec 31, 2018$391.70M+5.9%
FY2017Dec 31, 2017$369.90M+1.2%
FY2016Dec 31, 2016$365.60M+36.0%
FY2015Dec 31, 2015$268.80M+43.4%
FY2014Dec 31, 2014$187.40M-7.7%
FY2013Dec 31, 2013$203.00M-10.0%
FY2012Dec 31, 2012$225.60M-5.4%
FY2011Dec 31, 2011$238.40M+9.1%
FY2010Dec 31, 2010$218.50M+6.2%
FY2009Dec 31, 2009$205.70M+7.0%
FY2008Dec 31, 2008$192.30M+5.3%
FY2007Dec 31, 2007$182.60M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$104.80M-7.5%
Q1 FY2026Mar 31, 2026$103.40M-6.5%
Q4 FY2025Dec 31, 2025$118.70M+9.4%
Q3 FY2025Sep 30, 2025$115.90M+3.9%
Q2 FY2025Jun 30, 2025$113.30M+3.6%
Q1 FY2025Mar 31, 2025$110.60M+2.5%
Q4 FY2024Dec 31, 2024$108.50M-4.2%
Q3 FY2024Sep 30, 2024$111.60M-4.5%
Q2 FY2024Jun 30, 2024$109.40M-7.4%
Q1 FY2024Mar 31, 2024$107.90M-2.3%
Q4 FY2023Dec 31, 2023$113.30M+4.9%
Q3 FY2023Sep 30, 2023$116.90M+14.9%
Q2 FY2023Jun 30, 2023$118.10M+18.8%
Q1 FY2023Mar 31, 2023$110.40M+13.9%
Q4 FY2022Dec 31, 2022$108.00M+12.5%
Q3 FY2022Sep 30, 2022$101.70M+8.4%
Q2 FY2022Jun 30, 2022$99.40M-39.8%
Q1 FY2022Mar 31, 2022$96.90M+19.6%
Q4 FY2021Dec 31, 2021$96.00M+89.0%
Q3 FY2021Sep 30, 2021$93.80M+9.2%
Q2 FY2021Jun 30, 2021$165.00M+88.1%
Q1 FY2021Mar 31, 2021$81.00M-17.7%
Q4 FY2020Dec 31, 2020$50.80M-58.1%
Q3 FY2020Sep 30, 2020$85.90M-24.9%
Q2 FY2020Jun 30, 2020$87.70M-21.8%
Q1 FY2020Mar 31, 2020$98.40M-3.2%
Q4 FY2019Dec 31, 2019$121.10M+19.7%
Q3 FY2019Sep 30, 2019$114.40M+19.5%
Q2 FY2019Jun 30, 2019$112.10M+13.1%
Q1 FY2019Mar 31, 2019$101.70M+6.3%
Q4 FY2018Dec 31, 2018$101.20M+6.5%
Q3 FY2018Sep 30, 2018$95.70M+4.9%
Q2 FY2018Jun 30, 2018$99.10M+7.0%
Q1 FY2018Mar 31, 2018$95.70M+5.0%
Q4 FY2017Dec 31, 2017$95.00M-0.7%
Q3 FY2017Sep 30, 2017$91.20M-4.6%
Q2 FY2017Jun 30, 2017$92.60M–
Q1 FY2017Mar 31, 2017$91.10M–
Q4 FY2016Dec 31, 2016$95.70M–
Q3 FY2016Sep 30, 2016$95.60M–

More Zimmer Biomet figures

See a number that looks wrong?